The entire Bioconjugate Chemistry family has been impacted by the events of 2020, and we empathize with challenges, losses, and pain felt from each of the crises faced by humanity worldwide. Despite the trials we have faced in 2020, the year has had positive notes. As we look forward to 2021 with a renewed sense of hope, the Editorial Team at BC would like to share with you some of the bright spots of 2020. As highlighted below, the year brought life-changing scientific advances brought about by the BC community. Simultaneously, we at BC are working in partnership with the American Chemical Society to create and implement new policies and procedures targeting societal issues. We hope that the vignettes below convey our commitment to effecting change and express our sense of hope for the coming year. Finally, we want to thank you for being part of the BC community and wish you the very best for the coming year. Gang, Zhifei, Bradley, Jan, Erin, and Vince Views expressed in this editorial are those of the authors and not necessarily the views of the ACS. When the first wave of the COVID-19 pandemic hit North America in March, the normally bustling city of Toronto became a ghost town overnight, and a widespread panic arose in response to the threat of a brand-new, rapidly spreading disease shrouded in mystery. The research arm of the University Health Network—the largest hospital affiliated research institution in Canada—was shut down out of concern that hospitals would be rapidly overwhelmed. The research community responded to this threat with grace, resilience, collegiality, and ingenuity as they developed and deployed COVID-19 countermeasures with breathtaking speed. Now as the second wave of COVID-19 bears down upon us, society is far better prepared with effective mitigation strategies, deep scientific knowledge of this disease, and most importantly, the readiness of antibody therapeutics and vaccines, both of which have deep roots in Bioconjugate Chemistry. In particular, Pfizer/BioNtech and Moderna’s mRNA vaccines herald a new era in vaccinology by delivering the genetic sequences of specific viral proteins to host cells using lipid nanoparticle-based platforms. Undoubtedly, this is a “shot-in-the-arm” for the entire nanomedicine community, which will continue to be a major topic of interest for Bioconjugate Chemistry in the future. Gang Zheng, AE The year 2020 is a year of great concern regarding scientific innovation. Due to the COVID-19 pandemic, society has come to realize that the most powerful weapon for human beings against diseases is science and technology. The COVID-19 pandemic has prompted the global scientific and technological community to act together, greatly creating new kinetic energy for innovation and cooperation in the scientific community. The number of newly developed drugs and candidate vaccines against COVID-19 far exceeds the expectations that everyone had at the beginning of 2020. COVID-19 shows us that it is particularly important to carry out a wide range of scientific and technological cooperation to deal with each of the challenges that threaten the survival of mankind. Scientific and technological innovation is more and more becoming the key to influence and change the development of the world. The strong innovation capability of the global scientific community will certainly help us to make new breakthroughs and finally end the pandemic. We believe that the world will be better in 2021, and the future of mankind will be better in the long run! Zhifei Dai, AE What will be the new normal after the pandemic? In the case of science research and education, we have learned a great deal about the intricacies of remote work and communication. While there are some obvious negatives to this way of life, there are also many positives and the pandemic has forced many of us to rapidly overcome a technology learning curve that we may never have achieved under normal circumstances. Looking forward, we need to exploit this new skill set as a new normal for remote work and learning. There is great potential to improve work/life balance for many members of the STEM community. This large group of people includes working parents and caregivers, people who are physically unable to commute, and members of remote communities. While I look forward to further conference travel and meeting new and old friends from the BC community, I also recognize that conference travel has an inherent energy sustainability problem. I expect that the STEM community will embrace remote communications as a standard component of science research and teaching. We will lead society toward a more sustainable standard of living. Bradley Smith, AE The COVID pandemic has resulted in a reappreciation of science. Whereas previously there was only limited attention to new scientific discoveries (at least on Dutch television), now we are updated on a daily basis with the latest developments in immunology and epidemiology. The vast majority of our society values the factual and balanced approach followed by the researchers, and there is room for debate based on content. What is more, it is highly encouraging to see that in a very short time society has been able to develop a significant number of efficient vaccines, by sharing knowledge and by stimulating collaboration. We can achieve a lot when we remove unnecessary boundaries and provide sufficient means. Although developing a COVID vaccine is maybe a focused challenge, it makes me positive when I think about other grand challenges our society is facing, such as climate change. Maybe we can take the lessons learned from the COVID pandemic on how to effectively deal with an acute crisis and apply them to other areas where a concerted effort is needed from science, industry, and society as a whole. Jan van Hest, AE We need to draw on the expertise and perspective of the most diverse group of scientists possible to maximize the societal benefits provided by the scientific community. Research tells us that more diverse teams do better science. We cannot expect to take on the challenges of climate change, health disparities, or the next global crisis if we do not engage and include colleagues of different backgrounds, nationalities, gender identities, races, economic backgrounds, and abilities. We have to be willing to upend how we recruit, retain, and support scientists throughout the research enterprise including at journals like ours. As noted below, the ACS and BC are committed to addressing systemic racism and bias in the publishing process. One part of that is being able to have one’s papers reflect one’s identity. In August, a group of authors, led by Irving Rettig (who identifies as transgender), called on the ACS to revise their previously established name change policies. The ACS worked with Rettig to develop a new policy that enables authors to change their names on previous publications to match their current identity. This policy and its technical components allow authors to replace their name not only the original manuscript but in the metadata that pushes the information out to publishing aggregators and search engines. The new policy was announced in September and implemented in October 2020. After this rapid implementation, 24 authors have used this policy to change their name. I did not fully appreciate the impact of this effort until I talked with Jessica Rucker at ACS who worked with Rettig in designing and implementing the new policy. This conversation helped me understand the emotional cost of having to separate yourself from a body of work because the name associated with that work does not match your identity. Everyone deserves credit and celebration of their work, and being able to change a name on publications is a critical step in respecting the work of our authors. I am so grateful to ACS Publications, Jessica Rucker, and Irving Rettig for making this important change that is rapidly being adopted by other publishers. Erin Lavik, AE This year marked a watershed in our reckoning with racial justice. The tragedy of George Floyd’s death was a turning point in American society, affecting us all in different ways. Working together with a group of editors from other ACS journals, I addressed the issue of systemic racism in an editorial (https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.0c00358). This document is supported by the entire ACS portfolio of journals, and provides a manifesto for a more equitable future. Building on this document, ACS Publishing is instituting new measures to address systemic racism and bias in our publishing process. The BC Editorial Team is fully committed to these changes. As we state in our editorial, “The work will be difficult and force us to confront hard realities about our beliefs and actions. We fully expect that you, and everyone in the community, will hold us accountable.” Vincent M. Rotello, EIC This article has not yet been cited by other publications. When the first wave of the COVID-19 pandemic hit North America in March, the normally bustling city of Toronto became a ghost town overnight, and a widespread panic arose in response to the threat of a brand-new, rapidly spreading disease shrouded in mystery. The research arm of the University Health Network—the largest hospital affiliated research institution in Canada—was shut down out of concern that hospitals would be rapidly overwhelmed. The research community responded to this threat with grace, resilience, collegiality, and ingenuity as they developed and deployed COVID-19 countermeasures with breathtaking speed. Now as the second wave of COVID-19 bears down upon us, society is far better prepared with effective mitigation strategies, deep scientific knowledge of this disease, and most importantly, the readiness of antibody therapeutics and vaccines, both of which have deep roots in Bioconjugate Chemistry. In particular, Pfizer/BioNtech and Moderna’s mRNA vaccines herald a new era in vaccinology by delivering the genetic sequences of specific viral proteins to host cells using lipid nanoparticle-based platforms. Undoubtedly, this is a “shot-in-the-arm” for the entire nanomedicine community, which will continue to be a major topic of interest for Bioconjugate Chemistry in the future. Gang Zheng, AE The year 2020 is a year of great concern regarding scientific innovation. Due to the COVID-19 pandemic, society has come to realize that the most powerful weapon for human beings against diseases is science and technology. The COVID-19 pandemic has prompted the global scientific and technological community to act together, greatly creating new kinetic energy for innovation and cooperation in the scientific community. The number of newly developed drugs and candidate vaccines against COVID-19 far exceeds the expectations that everyone had at the beginning of 2020. COVID-19 shows us that it is particularly important to carry out a wide range of scientific and technological cooperation to deal with each of the challenges that threaten the survival of mankind. Scientific and technological innovation is more and more becoming the key to influence and change the development of the world. The strong innovation capability of the global scientific community will certainly help us to make new breakthroughs and finally end the pandemic. We believe that the world will be better in 2021, and the future of mankind will be better in the long run! Zhifei Dai, AE What will be the new normal after the pandemic? In the case of science research and education, we have learned a great deal about the intricacies of remote work and communication. While there are some obvious negatives to this way of life, there are also many positives and the pandemic has forced many of us to rapidly overcome a technology learning curve that we may never have achieved under normal circumstances. Looking forward, we need to exploit this new skill set as a new normal for remote work and learning. There is great potential to improve work/life balance for many members of the STEM community. This large group of people includes working parents and caregivers, people who are physically unable to commute, and members of remote communities. While I look forward to further conference travel and meeting new and old friends from the BC community, I also recognize that conference travel has an inherent energy sustainability problem. I expect that the STEM community will embrace remote communications as a standard component of science research and teaching. We will lead society toward a more sustainable standard of living. Bradley Smith, AE The COVID pandemic has resulted in a reappreciation of science. Whereas previously there was only limited attention to new scientific discoveries (at least on Dutch television), now we are updated on a daily basis with the latest developments in immunology and epidemiology. The vast majority of our society values the factual and balanced approach followed by the researchers, and there is room for debate based on content. What is more, it is highly encouraging to see that in a very short time society has been able to develop a significant number of efficient vaccines, by sharing knowledge and by stimulating collaboration. We can achieve a lot when we remove unnecessary boundaries and provide sufficient means. Although developing a COVID vaccine is maybe a focused challenge, it makes me positive when I think about other grand challenges our society is facing, such as climate change. Maybe we can take the lessons learned from the COVID pandemic on how to effectively deal with an acute crisis and apply them to other areas where a concerted effort is needed from science, industry, and society as a whole. Jan van Hest, AE We need to draw on the expertise and perspective of the most diverse group of scientists possible to maximize the societal benefits provided by the scientific community. Research tells us that more diverse teams do better science. We cannot expect to take on the challenges of climate change, health disparities, or the next global crisis if we do not engage and include colleagues of different backgrounds, nationalities, gender identities, races, economic backgrounds, and abilities. We have to be willing to upend how we recruit, retain, and support scientists throughout the research enterprise including at journals like ours. As noted below, the ACS and BC are committed to addressing systemic racism and bias in the publishing process. One part of that is being able to have one’s papers reflect one’s identity. In August, a group of authors, led by Irving Rettig (who identifies as transgender), called on the ACS to revise their previously established name change policies. The ACS worked with Rettig to develop a new policy that enables authors to change their names on previous publications to match their current identity. This policy and its technical components allow authors to replace their name not only the original manuscript but in the metadata that pushes the information out to publishing aggregators and search engines. The new policy was announced in September and implemented in October 2020. After this rapid implementation, 24 authors have used this policy to change their name. I did not fully appreciate the impact of this effort until I talked with Jessica Rucker at ACS who worked with Rettig in designing and implementing the new policy. This conversation helped me understand the emotional cost of having to separate yourself from a body of work because the name associated with that work does not match your identity. Everyone deserves credit and celebration of their work, and being able to change a name on publications is a critical step in respecting the work of our authors. I am so grateful to ACS Publications, Jessica Rucker, and Irving Rettig for making this important change that is rapidly being adopted by other publishers. Erin Lavik, AE This year marked a watershed in our reckoning with racial justice. The tragedy of George Floyd’s death was a turning point in American society, affecting us all in different ways. Working together with a group of editors from other ACS journals, I addressed the issue of systemic racism in an editorial (https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.0c00358). This document is supported by the entire ACS portfolio of journals, and provides a manifesto for a more equitable future. Building on this document, ACS Publishing is instituting new measures to address systemic racism and bias in our publishing process. The BC Editorial Team is fully committed to these changes. As we state in our editorial, “The work will be difficult and force us to confront hard realities about our beliefs and actions. We fully expect that you, and everyone in the community, will hold us accountable.” Vincent M. Rotello, EIC

中文翻译：

---

一月社论

整个生物共轭化学家族都受到了 2020 年事件的影响，我们对全球人类面临的每一次危机所带来的挑战、损失和痛苦深表同情。尽管我们在 2020 年面临考验，但这一年还是取得了积极进展。在我们怀着新的希望展望 2021 年的同时，BC 的编辑团队想与您分享 2020 年的一些亮点。如下所述，这一年带来了BC社区带来的改变生活的科学进步. 同时，我们在BC正在与美国化学学会合作，制定和实施针对社会问题的新政策和程序。我们希望下面的小插曲传达我们对实现变革的承诺，并表达我们对来年的希望。最后，我们要感谢您成为BC 的一员社区，并祝您在来年一切顺利。Gang、Zhifei、Bradley、Jan、Erin 和 Vince 在这篇社论中表达的观点是作者的观点，不一定是 ACS 的观点。当第一波 COVID-19 大流行在 3 月袭击北美时，原本熙熙攘攘的多伦多一夜之间变成了一座鬼城，一种笼罩在神秘之中的快速传播的全新疾病的威胁引起了广泛的恐慌。 . 大学健康网络的研究部门——加拿大最大的医院附属研究机构——因担心医院会迅速不堪重负而被关闭。研究界在以惊人的速度开发和部署 COVID-19 对策时，以优雅、弹性、合议和独创性应对了这一威胁。现在，随着第二波 COVID-19 向我们袭来，通过有效的缓解策略、对这种疾病的深入科学知识，以及最重要的是，抗体疗法和疫苗的准备就绪，社会已经做好了更好的准备，这两者都深深植根于生物共轭化学。特别是，辉瑞/BioNtech 和 Moderna 的 mRNA 疫苗通过使用基于脂质纳米颗粒的平台将特定病毒蛋白的基因序列传递给宿主细胞，预示着疫苗学的新时代。毫无疑问，这对整个纳米医学界来说是一个“武器”，未来将继续成为生物共轭化学感兴趣的主要话题。抗体疗法和疫苗的准备就绪，两者都深深植根于生物共轭化学。特别是，辉瑞/BioNtech 和 Moderna 的 mRNA 疫苗通过使用基于脂质纳米颗粒的平台将特定病毒蛋白质的基因序列传递给宿主细胞，预示着疫苗学的新时代。毫无疑问，这对整个纳米医学界来说是一个“武器”，未来将继续成为生物共轭化学感兴趣的主要话题。抗体疗法和疫苗的准备就绪，两者都深深植根于生物共轭化学。特别是，辉瑞/BioNtech 和 Moderna 的 mRNA 疫苗通过使用基于脂质纳米颗粒的平台将特定病毒蛋白质的基因序列传递给宿主细胞，预示着疫苗学的新时代。毫无疑问，这对整个纳米医学界来说是一个“武器”，未来将继续成为生物共轭化学感兴趣的主要话题。郑刚, AE2020年是科技创新备受关注的一年。由于 COVID-19 大流行，社会逐渐意识到人类对抗疾病的最有力武器是科学和技术。COVID-19大流行促使全球科技界齐心协力，极大地为科学界创新合作创造了新动能。针对 COVID-19 的新开发药物和候选疫苗的数量远远超出了 2020 年初大家的预期。 COVID-19 向我们表明，开展广泛的科技合作来应对尤为重要威胁人类生存的每一个挑战。科技创新越来越成为影响和改变世界发展的关键。全球科学界强大的创新能力，必将帮助我们取得新的突破，最终终结疫情。我们相信2021年世界会更美好，长远来看人类的未来会更美好！戴志飞, AE疫情过后的新常态是什么？在科学研究和教育方面，我们对远程工作和通信的复杂性有了很多了解。虽然这种生活方式有一些明显的负面影响，但也有很多积极因素，大流行迫使我们中的许多人迅速克服在正常情况下可能永远无法实现的技术学习曲线。展望未来，我们需要利用这种新技能作为远程工作和学习的新常态。对于 STEM 社区的许多成员来说，改善工作/生活平衡的潜力很大。这一大群人包括在职父母和照顾者、身体上无法通勤的人以及偏远社区的成员。虽然我期待着进一步的会议旅行和结识来自世界各地的新老朋友BC社区，我也认识到会议旅行具有固有的能源可持续性问题。我希望 STEM 社区将远程通信作为科学研究和教学的标准组成部分。我们将引领社会走向更可持续的生活水平。布拉德利·史密斯，AECOVID大流行使人们重新认识了科学。以前对新科学发现的关注有限（至少在荷兰电视上），而现在我们每天都会更新免疫学和流行病学的最新发展。我们社会的绝大多数人都重视研究人员遵循的事实和平衡的方法，并且存在基于内容的辩论空间。此外，通过分享知识和促进合作，社会在很短的时间内就能够开发出大量有效的疫苗，这是非常令人鼓舞的。当我们消除不必要的界限并提供足够的手段时，我们可以取得很多成就。尽管开发 COVID 疫苗可能是一个重点挑战，当我想到我们社会面临的其他重大挑战（例如气候变化）时，这让我感到乐观。也许我们可以从 COVID 大流行中汲取如何有效应对严重危机的经验教训，并将其应用于需要科学、工业和整个社会共同努力的其他领域。Jan van Hest, AE我们需要利用最多样化的科学家群体的专业知识和观点，以最大限度地提高科学界提供的社会效益。研究告诉我们，更多样化的团队做得更好。如果我们不让不同背景、国籍、性别认同、种族、经济背景和能力的同事参与进来，我们就不能指望应对气候变化、健康差异或下一次全球危机的挑战。我们必须愿意改变我们在整个研究企业中招募、留住和支持科学家的方式，包括在我们这样的期刊上。如下所述，ACS 和BC致力于解决出版过程中的系统性种族主义和偏见。其中一部分是能够让一个人的文件反映一个人的身份。8 月，由 Irving Rettig（认定为跨性别者）领导的一组作者呼吁 ACS 修改他们之前制定的更名政策。ACS 与 Rettig 合作制定了一项新政策，使作者能够更改以前出版物上的姓名以匹配他们当前的身份。该政策及其技术组件允许作者不仅可以替换原始手稿的姓名，还可以替换将信息推送到出版聚合器和搜索引擎的元数据中的姓名。新政策于 9 月公布，并于 2020 年 10 月实施。在这一快速实施之后，已有 24 位作者使用此政策更名。直到我与 ACS 的 Jessica Rucker 交谈后，我才完全意识到这项工作的影响，她与 Rettig 一起设计和实施了新政策。这次谈话帮助我理解了不得不将自己与工作分开的情感成本，因为与该工作相关的名称与您的身份不符。每个人的工作都值得赞扬和庆祝，能够在出版物上更改名称是尊重作者工作的关键一步。我非常感谢 ACS Publications、Jessica Rucker 和 Irving Rettig 做出的这一重要更改，并迅速被其他出版商采用。这次谈话帮助我理解了不得不将自己与工作分开的情感成本，因为与该工作相关的名称与您的身份不符。每个人的工作都值得赞扬和庆祝，能够在出版物上更改名称是尊重作者工作的关键一步。我非常感谢 ACS Publications、Jessica Rucker 和 Irving Rettig 做出的这一重要更改，并迅速被其他出版商采用。这次谈话帮助我理解了不得不将自己与工作分开的情感成本，因为与该工作相关的名称与您的身份不符。每个人的工作都值得赞扬和庆祝，能够在出版物上更改名称是尊重作者工作的关键一步。我非常感谢 ACS Publications、Jessica Rucker 和 Irving Rettig 做出的这一重要更改，并迅速被其他出版商采用。Erin Lavik, AE今年是我们对种族正义的清算的分水岭。乔治·弗洛伊德 (George Floyd) 之死的悲剧是美国社会的一个转折点，以不同的方式影响着我们所有人。我与来自其他 ACS 期刊的一组编辑合作，在一篇社论中讨论了系统性种族主义问题 (https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.0c00358)。该文件得到了整个 ACS 期刊组合的支持，并为更公平的未来提供了宣言。在此文件的基础上，ACS Publishing 正在制定新措施来解决我们出版过程中的系统性种族主义和偏见。在BC编辑团队完全致力于这些变化。正如我们在社论中所说，“这项工作将是艰巨的，并迫使我们面对关于我们的信仰和行动的严峻现实。我们完全期望您和社区中的每个人都对我们负责。” Vincent M. Rotello，EIC这篇文章还没有被其他出版物引用。当第一波 COVID-19 大流行于 3 月袭击北美时，原本熙熙攘攘的多伦多市一夜之间变成了鬼城，并引发了广泛的恐慌，以应对一种笼罩在神秘之中的快速传播的全新疾病的威胁. 大学健康网络的研究部门——加拿大最大的医院附属研究机构——因担心医院会迅速不堪重负而被关闭。研究界在以惊人的速度开发和部署 COVID-19 对策时，以优雅、弹性、合议和独创性应对了这一威胁。现在，随着第二波 COVID-19 向我们袭来，通过有效的缓解策略、对这种疾病的深入科学知识、最重要的是，抗体疗法和疫苗的准备就绪，两者都深深植根于生物共轭化学。特别是，辉瑞/BioNtech 和 Moderna 的 mRNA 疫苗通过使用基于脂质纳米颗粒的平台将特定病毒蛋白质的基因序列传递给宿主细胞，预示着疫苗学的新时代。毫无疑问，这对整个纳米医学界来说是一个“武器”，未来将继续成为生物共轭化学感兴趣的主要话题。郑刚, AE2020年是科技创新备受关注的一年。由于 COVID-19 大流行，社会逐渐意识到人类对抗疾病的最有力武器是科学和技术。COVID-19大流行促使全球科技界齐心协力，极大地为科学界创新合作创造了新动能。针对 COVID-19 的新开发药物和候选疫苗的数量远远超出了 2020 年初大家的预期。 COVID-19 向我们表明，开展广泛的科技合作来应对尤为重要威胁人类生存的每一个挑战。科技创新越来越成为影响和改变世界发展的关键。全球科学界强大的创新能力，必将帮助我们取得新的突破，最终终结疫情。我们相信2021年世界会更美好，长远来看人类的未来会更美好！戴志飞, AE疫情过后的新常态是什么？在科学研究和教育方面，我们对远程工作和通信的复杂性有了很多了解。虽然这种生活方式有一些明显的负面影响，但也有很多积极因素，大流行迫使我们中的许多人迅速克服在正常情况下可能永远无法实现的技术学习曲线。展望未来，我们需要利用这种新技能作为远程工作和学习的新常态。对于 STEM 社区的许多成员来说，改善工作/生活平衡的潜力很大。这一大群人包括在职父母和照顾者、身体上无法通勤的人以及偏远社区的成员。虽然我期待着进一步的会议旅行和结识来自世界各地的新老朋友BC社区，我也认识到会议旅行具有固有的能源可持续性问题。我希望 STEM 社区将远程通信作为科学研究和教学的标准组成部分。我们将引领社会走向更可持续的生活水平。布拉德利·史密斯，AECOVID大流行使人们重新认识了科学。以前对新科学发现的关注有限（至少在荷兰电视上），而现在我们每天都会更新免疫学和流行病学的最新发展。我们社会的绝大多数人都重视研究人员遵循的事实和平衡的方法，并且存在基于内容的辩论空间。此外，通过分享知识和促进合作，社会在很短的时间内就能够开发出大量有效的疫苗，这是非常令人鼓舞的。当我们消除不必要的界限并提供足够的手段时，我们可以取得很多成就。尽管开发 COVID 疫苗可能是一个重点挑战，当我想到我们社会面临的其他重大挑战（例如气候变化）时，这让我感到乐观。也许我们可以从 COVID 大流行中汲取如何有效应对严重危机的经验教训，并将其应用于需要科学、工业和整个社会共同努力的其他领域。Jan van Hest, AE我们需要利用最多样化的科学家群体的专业知识和观点，以最大限度地提高科学界提供的社会效益。研究告诉我们，更多样化的团队做得更好。如果我们不让不同背景、国籍、性别认同、种族、经济背景和能力的同事参与进来，我们就不能指望应对气候变化、健康差异或下一次全球危机的挑战。我们必须愿意改变我们在整个研究企业中招募、留住和支持科学家的方式，包括在我们这样的期刊上。如下所述，ACS 和BC致力于解决出版过程中的系统性种族主义和偏见。其中一部分是能够让一个人的文件反映一个人的身份。8 月，由 Irving Rettig（认定为跨性别者）领导的一组作者呼吁 ACS 修改他们之前制定的更名政策。ACS 与 Rettig 合作制定了一项新政策，使作者能够更改以前出版物上的姓名以匹配他们当前的身份。该政策及其技术组件允许作者不仅可以替换原始手稿的姓名，还可以替换将信息推送到出版聚合器和搜索引擎的元数据中的姓名。新政策于 9 月公布，并于 2020 年 10 月实施。在这一快速实施之后，已有 24 位作者使用此政策更名。直到我与 ACS 的 Jessica Rucker 交谈后，我才完全意识到这项工作的影响，她与 Rettig 一起设计和实施了新政策。这次谈话帮助我理解了不得不将自己与工作分开的情感成本，因为与该工作相关的名称与您的身份不符。每个人的工作都值得赞扬和庆祝，能够在出版物上更改名称是尊重作者工作的关键一步。我非常感谢 ACS Publications、Jessica Rucker 和 Irving Rettig 做出的这一重要更改，并迅速被其他出版商采用。这次谈话帮助我理解了不得不将自己与工作分开的情感成本，因为与该工作相关的名称与您的身份不符。每个人的工作都值得赞扬和庆祝，能够在出版物上更改名称是尊重作者工作的关键一步。我非常感谢 ACS Publications、Jessica Rucker 和 Irving Rettig 做出的这一重要更改，并迅速被其他出版商采用。这次谈话帮助我理解了不得不将自己与工作分开的情感成本，因为与该工作相关的名称与您的身份不符。每个人的工作都值得赞扬和庆祝，能够在出版物上更改名称是尊重作者工作的关键一步。我非常感谢 ACS Publications、Jessica Rucker 和 Irving Rettig 做出的这一重要更改，并迅速被其他出版商采用。Erin Lavik, AE今年是我们对种族正义的清算的分水岭。乔治·弗洛伊德 (George Floyd) 之死的悲剧是美国社会的一个转折点，以不同的方式影响着我们所有人。我与来自其他 ACS 期刊的一组编辑合作，在一篇社论中讨论了系统性种族主义问题 (https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.0c00358)。该文件得到了整个 ACS 期刊组合的支持，并为更公平的未来提供了宣言。在此文件的基础上，ACS Publishing 正在制定新措施来解决我们出版过程中的系统性种族主义和偏见。在BC编辑团队完全致力于这些变化。正如我们在社论中所说，“这项工作将是艰巨的，并迫使我们面对关于我们的信仰和行动的严峻现实。我们完全期望您和社区中的每个人都对我们负责。” Vincent M. Rotello，EIC